newest glp 1 drug Retatrutide for weight loss: Study shows 30% body weight loss Swiss Re says GLP-1 drugs

Although the scientific conclusions of the paper appear sound and its key findings have been extended by other investigators in independent publications, in an abundance of caution all authors who contributed experiments at the Broad Institute of MIT and Harvard support the Nature editors recommendation to retract the paper, says David Cameron, Broad Institutes director of communications

Protein intake is the single most important nutritional factor

M.MirhosseiniY.KhaksariM.et al (2021)

At Blue Haven Rx, we believe in a holistic approach to wellness

Clinical Evidence In a 2021 clinical trial (SURPASS-2), tirzepatide was found to have greater reductions in hemoglobin A1c (HbA1c) and body weight than semaglutide 1 mg in people with type 2 diabetes [6]

Cagrilintide: The Amylin Pathway Cagrilintide is an acylated analog of human amylin with a ~160-hour half-life (native amylin lasts ~15 minutes)